Clovis Oncology Hits Ch. 11 With $754.5M Debt And Sale Plans

By Jeff Montgomery · December 12, 2022, 10:21 AM EST

Clovis Oncology Inc. took its cancer-focused biopharmaceutical business into Chapter 11 in Delaware bankruptcy court on Sunday, reporting $319 million in assets and $754.5 million in debt, with a stalking horse...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Petition

Case Information

Case Title

Clovis Oncology, Inc.

Case Number

Court

Delaware

Nature of Suit

Date Filed

December 11, 2022

Recent Articles By Jeff

October 21, 2024
Apple Tells Del. Jury It Wants Smartwatch Infringing To Stop
September 06, 2024
Biopharm Co., Directors Sued In Del. Over 'Extreme' Scheme
September 04, 2024
J&J Hit With $1B Damages In Del. Merger Milestone Fight
July 18, 2024
Air Transport Co. Sued In Del. Over Director Removal Rule
July 16, 2024
Chancery Orders Illumina Docs Released In Grail Merger Fight
May 20, 2024
Healthcare Futures Co. Sues Breakaway Ex-Members In Del.
April 05, 2024
Med School Ex-CEO Sues For Legal Fees In Del. After Fraud Suit
April 05, 2024
New Chancery Challenge Launched To Board-Investor Pacts
February 21, 2024
Del. Suit Accuses Healthcare Data Co. Exec Of Insider Trading
February 06, 2024
Attys Seek $750K Fee In Del. For $6M Med Tech Co. Deal